Talk:Paroxetine
This is the talk page for discussing improvements to the Paroxetine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1, 2, 3Auto-archiving period: 180 days |
The subject of this article is controversial and content may be in dispute. When updating the article, be bold, but not reckless. Feel free to try to improve the article, but don't take it personally if your changes are reversed; instead, come here to the talk page to discuss them. Content must be written from a neutral point of view. Include citations when adding content and consider tagging or removing unsourced information. |
This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Paroxetine.
|
Addition of 'Aropax' to lead
[edit]I see this hasn't been discussed however, for the sake of a large Anglophone group in the Western World (including New Zealand, as well as a multitude of other South Pacific Island nation-states who purchase from Australian companies), I think the Trade name 'Aropax' should be included for searches by readers. I believe that the addition of one more Trade name is not a contravention of WP:NOTADVERTISING, nor is it WP:UNDUE/WP:PROMO any more than are "Paxil and Seroxat" (already being used in the lead). These may be common trade names in the US and/or Britain, but those names are never used over this side of the Anglophone world.
Please note that I am officially declaring that I have absolutely no WP:COI issues on this matter. I have no affiliation with any drug companies, nor do I know anyone who works for, distributes, etc. for any drug company. I have had no one approach me and ask that I endorse the product.
Note, also, that I am adding an addition reference which seems to be heavily drawn on, but not declared for this article available @ this link. There may be some problems with the article, but I'll run a check using the Wikipedia & other tools available before I comment further. Iryna Harpy (talk) 02:10, 28 May 2019 (UTC)
Binding profile
[edit]The ki's listed would benefit from (1) clarifying the source data point instead of adding references to the table header and (2) using only the minimum number of references required.―Biochemistry🙴❤ 22:39, 19 July 2020 (UTC)
Article repeats itself
[edit]This article repeats itself. In the introduction, right below the tables of info and facts, the adverse effects of Paroxetine are laid out. Then, below in the section named "Adverse Effects" the exact same text is used. This is redundant information that should be removed to keep the article as concise as possible. I would propose that the first occurence of this text should be removed. However, I do not feel it is my place to edit and remove such a large portion of the article.
//Jonte 94.255.206.141 (talk) 14:40, 31 August 2022 (UTC)
Inconsistency in medical uses - depression section
[edit]The depression subsection under medical uses claims that paroxetine is equivalent to placebo. I have checked the linked sources, and none of them supports this claim. Lukispooky (talk) 08:00, 24 June 2024 (UTC)
- Wikipedia controversial topics
- B-Class pharmacology articles
- High-importance pharmacology articles
- WikiProject Pharmacology articles
- B-Class medicine articles
- Mid-importance medicine articles
- B-Class psychiatry articles
- Unknown-importance psychiatry articles
- Psychiatry task force articles
- All WikiProject Medicine pages